Description |
protein kinase cAMP-dependent type I regulatory subunit beta |
retinoic acid receptor gamma |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Adapalene
- Acitretin
- Alitretinoin
- Tretinoin
- Tazarotene
- Etretinate
- Isotretinoin
- SR11254
- BMS-181156
- CD564
- Dodecyl-Alpha-D-Maltoside
- BMS184394
- R667
- LGD-1550
- 3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid
- 3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid
- Trifarotene
|
Diseases |
|
|
GWAS |
|
- Anthracycline-induced cardiotoxicity in childhood cancer ( 26237429)
- Cardiorespiratory fitness (800m run time) ( 32572135)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
|
Interacting Genes |
77 interacting genes:
AKAP1
AKAP14
AKAP7
ANKS1A
BAG3
BAG6
BOD1L2
CAMSAP1
CBX8
CCDC103
CCDC187
CDC37
CDKN1A
CEP19
COX5B
DACH1
DTNB
EEF2KMT
EGFR
FAM161A
FAM90A1
FCHSD2
GAS2L2
GLIS2
GNL3L
GOLGA1
GPKOW
GUCA1A
IGFN1
INPP5J
KANK2
KIF5B
L3MBTL2
LENG1
LNX1
MAD1L1
MBD3
MED8
MYO15B
NTAQ1
NXF1
PIK3R3
POLE4
PPP1R9A
PRKAA2
PRKACA
PRKAR1A
PRPF18
PSMG1
QRICH1
RARG
RUNX1T1
SAP30BP
SH2D4A
SHC3
SMAD3
SMAD4
SMG9
SNW1
STK16
SYTL4
TASOR2
TEAD4
THRA
TSGA10IP
UACA
VEZF1
WNK1
WRN
ZBTB16
ZMYND19
ZNF177
ZNF329
ZNF35
ZNF410
ZNF559-ZNF177
ZNF76
|
35 interacting genes:
ACY3
ARID1A
BBS4
HMGA1
IL24
ITGB1BP2
LSR
MAP6
MRPL12
MTMR6
MYF5
NCOA1
NCOA3
NCOR1
NCOR2
NEK9
NKX3-1
NR0B2
NR2F6
OIP5
PNRC1
PNRC2
PRIM1
PRKAR1B
PSMC5
RHPN2
RXRA
RXRB
RXRG
S100A3
SMAD3
SMARCD3
SPHK1
TNIP1
ZNF576
|
Entrez ID |
5575 |
5916 |
HPRD ID |
01485 |
01573 |
Ensembl ID |
ENSG00000188191
|
ENSG00000172819
|
Uniprot IDs |
P31321
|
A8K3H3
B7Z4B4
F1D8P1
P13631
|
PDB IDs |
4DIN
4F9K
|
1EXA
1EXX
1FCX
1FCY
1FCZ
1FD0
2LBD
3LBD
4LBD
5M24
6FX0
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|